Conjunctivitis Management
Avoid indiscriminate use of topical antibiotics or corticosteroids—most viral and mild bacterial conjunctivitis is self-limited, and treatment should be tailored to the specific etiology identified through clinical assessment 1.
Diagnostic Approach
The key to appropriate management is accurate differentiation of conjunctivitis type based on specific clinical features:
Bacterial Conjunctivitis
- Clinical clues: Mucopurulent discharge, eyelids matted shut on waking, lack of itching, no history of recurrent conjunctivitis 2, 3
- More common in children 2
- Natural history: Most uncomplicated cases resolve in 1-2 weeks without treatment 3
Viral Conjunctivitis
- Clinical clues: Watery discharge, more common in adults, variable presentation 2, 3
- Most common overall cause of infectious conjunctivitis 3
- Highly contagious: Adenovirus survives on surfaces for weeks 4
Allergic Conjunctivitis
- Clinical clues: Itching is the most consistent sign, watery discharge, bilateral presentation, environmental allergen exposure 2, 3
- Affects up to 40% of population 3
Management by Type
Bacterial Conjunctivitis
For uncomplicated bacterial conjunctivitis, delayed antibiotic prescribing achieves similar symptom control as immediate prescribing 2. This approach reduces unnecessary antibiotic use while maintaining patient safety.
Treatment algorithm:
- Mild cases: Conservative management with hygiene measures; most are self-limited 1, 3
- Moderate-to-severe or non-resolving cases: Topical antibiotics shorten duration and allow earlier return to work/school 3
- No single antibiotic is superior to others for routine bacterial conjunctivitis 1
Critical exceptions requiring immediate systemic therapy:
- Gonococcal conjunctivitis: Hyperacute, vision-threatening—requires immediate systemic antibiotics 1
- Chlamydial conjunctivitis: Requires systemic antibiotics plus topical therapy 3, 5
- Contact lens wearers: Must be treated with antibiotics due to risk of Pseudomonas and corneal involvement 3
Viral Conjunctivitis
Supportive care is the mainstay—viral conjunctivitis does not respond to antibacterial agents 1.
Treatment regimen:
- Artificial tears for symptom relief 2
- Cold compresses 2
- Topical antihistamines for comfort 2
- Povidone-iodine antiseptics show promise in reducing symptom duration 6
- Topical corticosteroids may reduce complications like subepithelial infiltrates in severe cases 6
Infection control is paramount:
- Strict hand hygiene—frequent handwashing 2
- Avoid touching eyes and sharing personal items 4
- School/work exclusion during acute phase 4
Allergic Conjunctivitis
Topical antihistamines with mast cell-stabilizing activity are first-line treatment 2, 3.
Treatment approach:
- Allergen avoidance when possible 7
- Topical antihistamines (primary therapy) 3
- Mast cell stabilizers 3
- For severe vernal conjunctivitis: Topical corticosteroids are necessary to control acute exacerbations 1
- Anti-inflammatory agents for refractory cases 5
Red Flags Requiring Urgent Ophthalmology Referral
Immediate specialist evaluation is indicated for 2:
- Neonatal conjunctivitis (risk of gonococcal/chlamydial infection)
- Severe eye pain or photophobia
- Reduced visual acuity
- Recent ocular surgery
- Vesicular rash on eyelids or nose (herpes zoster)
- Copious purulent discharge (possible gonococcal)
- Contact lens use with symptoms
- Immunocompromised state
- History of rheumatologic disease
Common Pitfalls to Avoid
Antibiotic overuse: The majority of conjunctivitis cases (viral and mild bacterial) are self-limited. Routine antibiotic prescribing contributes to antimicrobial resistance without improving outcomes 1, 8. Consider delayed prescribing strategies for uncomplicated bacterial cases 2.
Inappropriate corticosteroid use: Never use topical steroids empirically without establishing etiology—they can worsen herpetic infections and are unnecessary for routine viral or bacterial conjunctivitis 1. Reserve steroids for severe vernal conjunctivitis or complicated viral cases with subepithelial infiltrates under ophthalmology guidance 1, 6.
Missing underlying conditions: Always address coexisting blepharitis, dry eye, or systemic diseases (thyroid disorders, sleep apnea, sexually transmitted infections) that may be contributing to or causing the conjunctival inflammation 1.
Herpes zoster vaccination: Strongly recommend vaccination for patients ≥50 years or immunocompromised patients ≥19 years to prevent zoster-related conjunctivitis and keratitis 1.